Page:Iraqdossier.djvu/15

 helped to develop the programme. At about the same time plans were made to develop the Salman Pak site into a secure biological warfare research facility. Dr Taha continued to work with her team at al-Muthanna until 1987 when it moved to Salman Pak, which was under the control of the Directorate of General Intelligence. Significant resources were provided for the programme, including the construction of a dedicated production facility (Project 324) at al-Hakam. Agent production began in 1988 and weaponisation testing and later filling of munitions was conducted in association with the staff at Muthanna State Establishment. From mid-1990, other civilian facilities were taken over and some adapted for use in the production and research and development of biological agents. These included: al-Dawrah Foot and Mouth Vaccine Institute which produced botulinum   toxin and conducted virus research. There is some intelligence to suggest  that work was also conducted on anthrax; al-Fudaliyah Agriculture and Water Research Centre where Iraq admitted it   undertook aflatoxin production and genetic engineering; Amariyah Sera and Vaccine Institute which was used for the storage of   biological agent seed stocks and was involved in genetic engineering.

By the time of the Gulf War Iraq was producing very large quantities of chemical and biological agents. From a series of Iraqi declarations to the UN during the 1990s we know that by 1991 they had produced at least: 12 19,000 litres of botulinum toxin, 8,500 litres of anthrax, 2,200 litres of aflatoxin and were working on a number of other agents; 12